Artrya Ltd has released a press release.
FDA clearance of Salix Coronary Plaque module
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Artrya
- Appendix 4E and Annual Financial Statements
- AYA Signs US$0.6m Five Year Contract with Tanner Health
- Artrya Leadership Transition
- Artrya Secures Contract with Lumas Imaging
- Artrya Secures FDA Clearance for Salix Coronary Anatomy
Later from Artrya
- Trading Halt
- Successful A$75 million placement and launch of SPP
- Completion of Share Purchase Plan
- Completion of Placement and Cleansing Notice
- Mass General Brigham to Participate in SAPPHIRE Study
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya